Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 09, 2010 06:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Announces Update on Antifolate Clinical Program

CHARLOTTE, N.C., June 9, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that during a teleconference yesterday, the U.S. Food and Drug Administration (FDA)...
June 03, 2010 08:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at 9th Annual Needham Healthcare Conference

CHARLOTTE, N.C., June 3, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 9th Annual Needham Healthcare Conference at 2:00 PM ET on...
May 18, 2010 08:47 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Data From Study 303 Confirming Safety and Robust Therapeutic Benefit of Long-Term Northera Treatment in Neurogenic Orthostatic Hypotension

Northera Provides Sustained Improvements in Both Blood Pressure and Symptoms of Neurogenic Orthostatic Hypotension Patients Maintain Statistically Significant 3.2 unit Improvement in OHQ...
April 29, 2010 16:15 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports First Quarter 2010 Results

Full Enrollment of Study 301 on Track for Completion by End of Second Quarter; Data Expected in Third Quarter 2010 Study 306 On Track to Begin Enrollment in Second Quarter; Data...
April 22, 2010 08:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Host Conference Call to Discuss First Quarter 2010 Results

CHARLOTTE, N.C., April 22, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release first quarter results for the period ended March 31, 2010...
April 06, 2010 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at the Future Leaders in the Biotech Industry Conference

CHARLOTTE, N.C., April 6, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 17th Annual Future Leaders in the Biotech Industry Conference...
March 17, 2010 09:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Findings From Northera 24-Hour Blood Pressure Monitoring Study

Northera Effectively Increases SBP in Patients With Neurogenic Orthostatic Hypotension Patients Showed Mean Diurnal Increase of 8.4 mmHg SBP and Mean Nocturnal Increase of 7.8 mmHg SBP While...
March 12, 2010 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at the ROTH 22nd Annual OC Growth Stock Conference on Wednesday, March 17, 2010

CHARLOTTE, N.C., March 12, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the ROTH 21st Annual OC Growth Stock Conference at 11:00 AM PT on...
March 10, 2010 16:25 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Fourth Quarter and Full Year 2009 Results

CHARLOTTE, N.C., March 10, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the fourth quarter and full year 2009 and will host a...
March 05, 2010 13:20 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Completes $18.2 Million Registered Direct Offering

CHARLOTTE, N.C., March 5, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it completed its previously announced registered direct offering to...